RECIST 1.1, mRECIST, and Choi criteria for evaluating treatment response and survival outcomes in hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab
Titel:
RECIST 1.1, mRECIST, and Choi criteria for evaluating treatment response and survival outcomes in hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab
Auteur:
Kim, Dong Hwan Min, Eun Jeong Kim, Bohyun Choi, Jong Young Jang, Jeong Won Sung, Pil Soo Han, Ji Won Kim, Hokun Choi, Joon-Il